Fitriana Mawardi | Health Professions | Best Researcher Award

Best Researcher Award

Fitriana Mawardi — Universitas Ahmad Dahlan, Indonesia

Fitriana Mawardi
Affiliation Universitas Ahmad Dahlan
Country Indonesia
Scopus ID 57219221778
Documents 12
Citations 97
h-index 6
Subject Area Health Professions
Event International Research Awards

The Best Researcher Award recognizes scholarly excellence, scientific productivity, and sustained academic contributions within specialized research domains. Fitriana Mawardi, affiliated with Universitas Ahmad Dahlan in Indonesia, has established a developing research profile in the area of Clinical Pharmacist’s Authority through peer-reviewed publications, citation impact, and interdisciplinary academic engagement.[1] The recognition is associated with the International Research Awards program, which acknowledges emerging and established researchers demonstrating measurable contributions to scientific advancement and academic dissemination.[2]

Abstract

This academic article presents a structured overview of the research profile, scholarly contributions, and citation performance of Fitriana Mawardi in the field of Clinical Pharmacist’s Authority. The article highlights bibliometric indicators, publication activity, and research influence relevant to the Best Researcher Award presented under the International Research Awards initiative. The assessment emphasizes publication visibility, citation-based influence, interdisciplinary relevance, and contributions to healthcare and pharmaceutical practice.[1]

Keywords

Clinical Pharmacy, Pharmacist Authority, Healthcare Research, Pharmaceutical Sciences, Citation Analysis, Research Metrics, Academic Recognition, International Research Awards, Scopus Author Profile, Scholarly Publications.

Introduction

Academic recognition programs frequently evaluate researchers through measurable scholarly indicators including publication volume, citation performance, collaboration patterns, and research relevance.[2] In healthcare and pharmaceutical sciences, research concerning pharmacist authority and clinical interventions has become increasingly important due to evolving patient-centered care systems and evidence-based therapeutic management.[3]

Fitriana Mawardi’s academic profile reflects participation in this expanding research landscape through indexed scholarly outputs and citation engagement. The Best Researcher Award nomination framework aligns with internationally recognized academic assessment practices that emphasize scientific dissemination, knowledge transfer, and research visibility.[1]

Research Profile

Fitriana Mawardi is affiliated with Universitas Ahmad Dahlan, Indonesia, and has developed a research portfolio connected to Clinical Pharmacist’s Authority and related pharmaceutical and healthcare disciplines. Bibliometric data indexed through Scopus identifies 12 scholarly documents with a cumulative citation count of 97 and an h-index of 6.[1]

  • Affiliation with Universitas Ahmad Dahlan and participation in healthcare-related academic research.
  • Research activity indexed within Scopus-authorized bibliometric databases.
  • Scholarly engagement associated with pharmaceutical practice and pharmacist authority frameworks.
  • Evidence of measurable citation impact and publication continuity.

Research Contributions

Research contributions associated with Clinical Pharmacist’s Authority generally involve pharmaceutical care optimization, healthcare service evaluation, medication management, and patient-centered clinical interventions.[3] Scholarly investigations in this area contribute to evidence-based healthcare policies and support the advancement of pharmacy practice within multidisciplinary medical systems.

The publication profile of Fitriana Mawardi demonstrates engagement with contemporary healthcare research themes, including pharmaceutical service quality, therapeutic management, and clinical decision-making processes. These research activities support the broader objective of improving healthcare outcomes through systematic scientific investigation.[4]

  • Clinical pharmacy and healthcare practice evaluation.
  • Medication management and pharmaceutical care research.
  • Patient-centered healthcare and evidence-based intervention studies.
  • Research dissemination through indexed scholarly publications.

Publications

The publication record indexed under Scopus demonstrates continuing scholarly productivity and participation in peer-reviewed academic communication. Indexed research outputs contribute to citation accumulation and academic visibility within pharmaceutical and healthcare research communities.[1]

  1. Research articles associated with pharmaceutical practice and healthcare systems.
  2. Studies related to pharmacist intervention and medication management.
  3. Peer-reviewed publications contributing to healthcare evidence frameworks.
  4. Collaborative scholarly outputs indexed in international academic databases.

Several scholarly outputs within pharmaceutical and healthcare disciplines frequently incorporate DOI-based publication indexing standards to improve digital accessibility and citation tracking.[5]

Research Impact

Bibliometric indicators are commonly used to evaluate scientific influence and scholarly dissemination. The documented citation count of 97 and h-index of 6 indicate measurable engagement with the published research contributions associated with Fitriana Mawardi.[1] Citation activity reflects academic utilization, scholarly referencing, and relevance within the broader research ecosystem.

Research impact within healthcare and pharmaceutical sciences extends beyond numerical indicators and includes educational value, healthcare policy relevance, and practical implications for patient care systems.[3]

  • 97 cumulative citations recorded within indexed academic databases.
  • h-index of 6 indicating recurring citation influence across publications.
  • Visibility through international scholarly indexing systems.
  • Contribution to healthcare-oriented academic literature.

Award Suitability

The Best Researcher Award framework emphasizes scientific consistency, publication quality, citation engagement, and subject-specific scholarly relevance. Fitriana Mawardi’s indexed publication record, citation performance, and healthcare-oriented research profile align with evaluation standards commonly used in international academic recognition programs.[2]

The demonstrated research activity within Clinical Pharmacist’s Authority supports the objectives of academic excellence, interdisciplinary healthcare research, and evidence-based pharmaceutical advancement. These characteristics contribute to the suitability of the researcher for recognition within the International Research Awards platform.[4]

Conclusion

The academic profile of Fitriana Mawardi demonstrates measurable scholarly activity within pharmaceutical and healthcare research. Indexed publications, citation performance, and subject-area engagement collectively indicate an active contribution to Clinical Pharmacist’s Authority research and related healthcare disciplines. The bibliometric indicators and publication record support consideration within internationally recognized academic award programs focused on research productivity and scholarly impact.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Fitriana Mawardi, Author ID 57219221778. Scopus.https://www.scopus.com/authid/detail.uri?authorId=57219221778
  2. International Research Awards. (n.d.). Award evaluation and academic recognition criteria.https://researchawards.net/
  3. British Journal of Clinical Pharmacology.(2025). Infringement of clinical pharmacist’s authority. https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bcp.16161
  4. World Health Organization. (2021). Healthcare systems and pharmaceutical practice research.https://www.who.int/
  5. Journal of Medical Ethics (2025). Javanese ethical concepts in health and healing.https://doi.org/10.1136/jme-2025-111335/

Aliyar Mirzapour | Medicine and Health Sciences | Editorial Board Member

Assist Prof Dr. Aliyar Mirzapour | Medicine and Health Sciences | Editorial Board Member 

Departement of parasitology and Mycology, School of Medicine Islamic Azad University Mashhad Branch | Iran

Dr. Aliyar Mirzapour is an accomplished Iranian parasitologist and medical researcher affiliated with the Department of Parasitology and Mycology, School of Medicine, Islamic Azad University, Mashhad Branch. His scholarly contributions span a wide range of parasitic diseases, with a strong emphasis on systematic reviews, meta-analyses, molecular diagnostics, zoonotic parasites, and epidemiological patterns of infections affecting both humans and animals. Over the years, Mirzapour has contributed significantly to understanding soil-transmitted helminths, protozoan infections, zoonotic risks, and vector-borne diseases prevalent in Iran and across the globe. His work has been widely referenced, demonstrating growing recognition within the parasitology and public health communities. One of his most influential collaborations includes research on Toxoplasma gondii and Toxocara spp., where he co-authored systematic reviews and meta-analyses exploring global and regional prevalence, geo-climatic factors influencing infection, and the potential association of parasitic exposure with neurological disorders such as schizophrenia. These studies have provided valuable insights into risk factors, transmission dynamics, and the public health burden of toxoplasmosis and toxocariasis, helping policymakers prioritize preventive strategies. Mirzapour has also contributed to investigations on soil contamination in public areas, documenting the presence of Toxocara eggs and Toxoplasma oocysts, which represent critical sources of human infection. His work in this area has strengthened awareness about environmental hygiene and zoonotic disease management. In addition to epidemiological research, Mirzapour has conducted laboratory-based and molecular studies focused on Leishmania species, Echinococcus granulosus, nontuberculous mycobacteria, and helminths. Notably, he has published reports on cutaneously infected patients with mixed Leishmania species, explored intra-species diversity using ITS1-rDNA analysis, and participated in designing multi-epitope recombinant antigens aimed at improving diagnostic accuracy for cystic echinococcosis. His work on immunomodulation, particularly studies involving naltrexone and naloxone as vaccine adjuvants against Fasciola hepatica, reflects his interest in advancing vaccine formulations and host-immune response research. Mirzapour’s contributions further include parasitological surveys in wildlife and zoo animals, identification of rare parasites such as Bivitellobilharzia nairi in elephants, and diagnostic studies using high-performance liquid chromatography for Mycobacterium species differentiation. His broad expertise, spanning field sampling, molecular techniques, immunology, and evidence synthesis, highlights his dedication to improving parasitic disease control and public health outcomes. Through consistent publication and collaboration, Aliyar Mirzapour has established himself as a valuable researcher in contemporary parasitology.

Profile: Google Scholar

Featured Publications

Behravan, M., Panahi, A. H., Naghizadeh, A., Ziaee, M., Mahdavi, R., … (2018). Facile green synthesis of silver nanoparticles using Berberis vulgaris leaf and root aqueous extract and its antibacterial activity. International Journal of Biological Macromolecules, 781.

Maleki, B., Ahmadi, N., Olfatifar, M., Gorgipour, M., Taghipour, A., Abdoli, A., … (2021). Toxoplasma oocysts in the soil of public places worldwide: A systematic review and meta-analysis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 115(5), 53.

Maleki, B., Khorshidi, A., Gorgipour, M., Mirzapour, A., … (2017). Prevalence of Toxocara spp. eggs in soil of public areas in Iran: A systematic review and meta-analysis. Alexandria Journal of Medicine, 52.

Rostami, A., Riahi, S. M., Omrani, V. F., Wang, T., … (2020). Global prevalence estimates of Toxascaris leonina infection in dogs and cats. Pathogens, 9(6), 503.

Nourollahpour Shiadeh, M., Esfandyari, S., Ashrafmansouri, M., … (2020). The prevalence of latent and acute toxoplasmosis in HIV-infected pregnant women: A systematic review and meta-analysis. Microbial Pathogenesis, 45(10), 149.

Rostami, A., Riahi, S. M., Esfandyari, S., Habibpour, H., … (2021). Geo-climatic factors and prevalence of chronic toxoplasmosis in pregnant women: A meta-analysis and meta-regression. Environmental Pollution, 288.

Taghipour, A., Habibpour, H., & Mirzapour, A. (2021). Toxocara infection/exposure and the risk of schizophrenia: A systematic review and meta-analysis. Transactions of the Royal Society of Tropical Medicine & Hygiene, 115(3), 18.

Mirzapour, A., Kiani, H., Mobedi, I., Spotin, A., Tabaei, S. J. S., & Rahimi, M. (2018). Frequency of intestinal parasites among zoo animals by morphometric criteria and first report of the Bivitellobilharzia nairi from elephant (Elephas maximus maximus) in Iran. Iranian Journal of Parasitology, 13(4), 611.